nccn guidelines for dlbcl surveillance

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
nccn guidelines for dlbcl surveillance	0.02	0.6	1620	43	38
nccn	0.97	0.5	7352	70	4
guidelines	1.42	1	1572	60	10
for	0.35	0.1	1785	66	3
dlbcl	1.16	0.4	5516	84	5
surveillance	0.76	0.5	1471	77	12

Keyword	CPC	PCC	Volume	Score
nccn guidelines for dlbcl surveillance	0.58	0.5	9776	49
nccn guidelines for dlbcl	0.01	0.9	5486	7
nccn dlbcl guidelines 2023	0.46	0.8	7834	61
nccn guidelines bladder cancer surveillance	0.75	0.3	8915	21
nccn guidelines for nsclc	0.32	0.9	1105	65
nccn guidelines diffuse large b cell lymphoma	1.48	0.9	8076	95
nccn guidelines breast cancer surveillance	1.77	0.9	2876	18
nccn guidelines acute lymphoblastic leukemia	0.71	1	8318	70
nccn b cell lymphoma guidelines	0.82	0.3	9768	39
dlbcl with cns involvement	1.45	0.1	1395	69
nccn guidelines with evidence blocks	1.02	0.3	9213	72
tnbc treatment guidelines nccn	0.8	0.3	3742	98
nccn cll evidence blocks	2	0.9	3093	48
nciccr-dlbcl	0.44	0.5	8498	83
nccn guidelines for treatment of dlbcl	0.59	0.3	251	52
nccn guidelines for cll	0.79	0.3	9595	58
nccn guidelines b cell lymphomas	1.09	0.1	3933	58
nccn guidelines for cml	1.45	1	8990	55
nccn cll treatment guidelines	0.82	0.1	1368	49
nccn guidelines 2022 cll	1.76	0.7	2678	81
first line treatment for dlbcl	1.73	0.2	7493	18
non gcb dlbcl treatment	1.38	0.6	167	30
dlbcl standard of care	1.59	0.7	8344	100